ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2024, 'Validation of the psychosocial consequences of screening in lung cancer questionnaire in the international lung screen trial Australian cohort', Health and Quality of Life Outcomes, 22, http://dx.doi.org/10.1186/s12955-023-02225-8
,2024, 'The TSANZ and Lung Foundation Australia 2023 landscape survey of lung cancer care across Australia and Aotearoa New Zealand', Respirology, 29, pp. 405 - 412, http://dx.doi.org/10.1111/resp.14693
,2024, 'A Prospective Observational Study of Physical Activity Levels and Physical Fitness of People at High Risk for Lung Cancer', JTO Clinical and Research Reports, 5, http://dx.doi.org/10.1016/j.jtocrr.2024.100633
,2024, '“We need to work towards it, whatever it takes.”—participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders', Translational Lung Cancer Research, 13, pp. 240 - 255, http://dx.doi.org/10.21037/tlcr-23-623
,2024, 'Carrying on with life as a lung cancer survivor: a qualitative study of Australian survivors’ employment, finances, relationships, and healthcare experiences', Translational Lung Cancer Research, 13, pp. 785 - 798, http://dx.doi.org/10.21037/tlcr-23-815
,2023, 'Implementing Smoking Cessation Interventions for Tobacco Users Within Oncology Settings: A Systematic Review', JAMA Oncology, 9, pp. 981 - 1000, http://dx.doi.org/10.1001/jamaoncol.2023.0031
,2023, 'Advances in lung cancer: a ground-breaking decade', The Lancet Respiratory Medicine, 11, pp. 407 - 409, http://dx.doi.org/10.1016/S2213-2600(23)00133-9
,2023, '"What do i think about implementing lung cancer screening? It all depends on how." Acceptability and feasibility of lung cancer screening in Australia: The view of key stakeholders about health system factors', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0283939
,2023, 'Education messages and strategies to inform the public, potential screening candidates and healthcare providers about lung cancer screening: A systematic review', Preventive Medicine, 169, http://dx.doi.org/10.1016/j.ypmed.2023.107459
,2023, 'Lung cancer screening: The hidden public health emergency', Public Health Research and Practice, 33, http://dx.doi.org/10.17061/phrp3312302
,2023, 'Lung cancer screening', The Lancet, 401, pp. 390 - 408, http://dx.doi.org/10.1016/S0140-6736(22)01694-4
,2023, 'Economic impact of using risk models for eligibility selection to the International lung screening Trial', Lung Cancer, 176, pp. 38 - 45, http://dx.doi.org/10.1016/j.lungcan.2022.12.011
,2023, 'A Systematic Review of Electronic Medical Record Driven Quality Measurement and Feedback Systems', International Journal of Environmental Research and Public Health, 20, http://dx.doi.org/10.3390/ijerph20010200
,2023, 'An update on long COVID and its management', Medicine Today, 24, pp. 37 - 43
,2023, 'Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors’ experiences of ongoing physical effects, novel treatments, uncertainty, and coping', Journal of Cancer Survivorship, http://dx.doi.org/10.1007/s11764-023-01417-x
,2023, 'Building on a Legacy', JTO Clinical and Research Reports, 4, http://dx.doi.org/10.1016/j.jtocrr.2022.100445
,2023, 'Lung Cancer Screening: Implementation Challenges and Health Equity Considerations For the Western Pacific Region', JCO global oncology, 9, pp. e2200329, http://dx.doi.org/10.1200/GO.22.00329
,2023, 'Recreational vaping ban in Australia—policy failure or masterstroke?', The Lancet, http://dx.doi.org/10.1016/S0140-6736(23)02298-5
,2023, 'Accelerating implementation of lung cancer screening in Australia: what evidence-based strategies are recommended?', Lung Cancer, 178, pp. S66 - S66, http://dx.doi.org/10.1016/s0169-5002(23)00579-2
,2023, 'EP17.01-01 The Lung Cancer Clinical Quality Data Platform (LUCAP): Results from a Western Australia Pilot Study', Journal of Thoracic Oncology, 18, pp. S733 - S734, http://dx.doi.org/10.1016/j.jtho.2023.09.1418
,2023, 'EP17.01-05 Lung Cancer (Internet-Based) Delphi (LuCiD): a Delphi Consensus to Develop Australasian Thoracic Oncology Quality Indicators', Journal of Thoracic Oncology, 18, pp. S735 - S736, http://dx.doi.org/10.1016/j.jtho.2023.09.1422
,2023, 'MA03.09 Embedding Smoking Cessation into a Potential Lung Cancer Screening Program: Australian Tobacco Control Expert Perspectives', Journal of Thoracic Oncology, 18, pp. S108 - S108, http://dx.doi.org/10.1016/j.jtho.2023.09.133
,2023, 'P1.01-12 “A Core Part of the Whole Thing...”: Stakeholder Views on Offering Smoking Cessation Support in Lung Cancer Screening', Journal of Thoracic Oncology, 18, pp. S186 - S187, http://dx.doi.org/10.1016/j.jtho.2023.09.290
,2022, 'Contemporary Concise Review 2021: Pulmonary nodules from detection to intervention', Respirology, 27, pp. 776 - 785, http://dx.doi.org/10.1111/resp.14296
,2022, 'Motivation is not enough: A qualitative study of lung cancer screening uptake in Australia to inform future implementation', PLoS ONE, 17, http://dx.doi.org/10.1371/journal.pone.0275361
,2022, 'Severe disseminated primary varicella in a patient on long term inhaled corticosteroids', Respirology Case Reports, 10, http://dx.doi.org/10.1002/rcr2.1010
,2022, 'The Tobacco Endgame—A New Paradigm for Smoking Cessation in Cancer Clinics', Current Oncology, 29, pp. 6325 - 6333, http://dx.doi.org/10.3390/curroncol29090497
,2022, 'Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2022-060907
,2022, 'Sustaining the Australian respiratory workforce through the COVID-19 pandemic: a scoping literature review', Internal Medicine Journal, 52, pp. 1115 - 1122, http://dx.doi.org/10.1111/imj.15718
,2022, 'Hospital-based multidisciplinary lung cancer care in Australia: A survey of the landscape in 2021', BMJ Open Respiratory Research, 9, http://dx.doi.org/10.1136/bmjresp-2021-001157
,2022, 'USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study', The Lancet Oncology, 23, pp. 138 - 148, http://dx.doi.org/10.1016/S1470-2045(21)00590-8
,2022, 'EP01.02-004 Education Messages and Strategies About Lung Cancer Screening: A Systematic Review', Journal of Thoracic Oncology, 17, pp. S168 - S168, http://dx.doi.org/10.1016/j.jtho.2022.07.278
,2022, 'EP01.03-006 Potential Drivers of Lung Cancer Screening Participation in Australia: A Qualitative Study to Inform Future Implementation', Journal of Thoracic Oncology, 17, pp. S174 - S174, http://dx.doi.org/10.1016/j.jtho.2022.07.288
,2022, 'EP01.03-012 Acceptability and Feasibility of Lung Cancer Screening in Australia: The View of Key Stakeholders', Journal of Thoracic Oncology, 17, pp. S177 - S177, http://dx.doi.org/10.1016/j.jtho.2022.07.294
,2022, 'EP10.01-005 Australian Lung Cancer Survivors Experiences of Novel Treatments, Healthcare, and Ongoing Physical and Psychological Needs', Journal of Thoracic Oncology, 17, pp. S502 - S502, http://dx.doi.org/10.1016/j.jtho.2022.07.882
,2021, 'Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres', Implementation Science, 16, pp. 23, http://dx.doi.org/10.1186/s13012-021-01092-5
,2021, 'Variations in lung cancer care and outcomes: How best to identify and improve standards of care?', Respirology, 26, pp. 1103 - 1105, http://dx.doi.org/10.1111/resp.14155
,2021, 'Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review', Frontiers in Oncology, 11, http://dx.doi.org/10.3389/fonc.2021.701424
,2021, 'Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary Authorships', Journal of Thoracic Oncology, 16, pp. 706 - 708, http://dx.doi.org/10.1016/j.jtho.2021.03.005
,2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963
,2021, 'OA19.01 Prospective Study of Lung Cancer Screening Criteria: USPSTF2013 vs PLCOm2012 – International Lung Screening Trial (ILST) Results', Journal of Thoracic Oncology, 16, pp. S881 - S881, http://dx.doi.org/10.1016/j.jtho.2021.08.097
,2021, 'P41.07 Lung Cancer Screening: What is the State of the Evidence about Implementation?', Journal of Thoracic Oncology, 16, pp. S475 - S475, http://dx.doi.org/10.1016/j.jtho.2021.01.821
,2021, 'P60.01 Single-Cell Transcriptomics to Assess Response to Immunotherapy in Advanced Lung Cancer ex-vivo: Developing a Functional Predictive Assay', Journal of Thoracic Oncology, 16, pp. S540 - S541, http://dx.doi.org/10.1016/j.jtho.2021.01.960
,2020, 'Essential update in lung cancer medicine', Respirology, 25, pp. 3 - 4, http://dx.doi.org/10.1111/resp.13968
,2020, 'Medicolegal Considerations in Multidisciplinary Cancer Care', JTO Clinical and Research Reports, 1, http://dx.doi.org/10.1016/j.jtocrr.2020.100073
,2020, 'Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*', Respirology, 25, pp. 1082 - 1089, http://dx.doi.org/10.1111/resp.13904
,2020, 'Multidisciplinary team care in lung cancer', Translational Lung Cancer Research, 9, pp. 1625 - 1628, http://dx.doi.org/10.21037/tlcr-2020-lcmc-08
,2020, 'Optimizing lung cancer MDT data for maximum clinical impact-a scoping literature review', Translational Lung Cancer Research, 9, pp. 1629 - 1638, http://dx.doi.org/10.21037/tlcr.2020.01.02
,2020, 'Molecular testing of metastatic non-small cell lung cancer in the Asia-Pacific region', Respirology, 25, pp. 685 - 687, http://dx.doi.org/10.1111/resp.13833
,2020, 'Clinical impact of data feedback at lung cancer multidisciplinary team meetings: A mixed methods study', Asia-Pacific Journal of Clinical Oncology, 16, pp. 45 - 55, http://dx.doi.org/10.1111/ajco.13278
,